<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30241269</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">2378-9506</ISSN>                <JournalIssue CitedMedium="Internet">                    <Issue>4</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of global oncology</Title>                <ISOAbbreviation>J Glob Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>Data Reliability and Coding Completeness of Cancer Registry Information Using Reabstracting Method in the National Cancer Institute: Thailand, 2012 to 2014.</ArticleTitle>            <Pagination>                <MedlinePgn>1-9</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1200/JGO.17.00147</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Data quality is a core value of cancer registries, which bring about greater understanding of cancer distribution and determinants. Thailand established its cancer registry in 1986; however, studies focusing on data reliability have been limited. This study aimed to assess the coding completeness and reliability of the National Cancer Institute (NCI) hospital-based cancer registry, Thailand.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">This study was conducted using the reabstracting method. We focused on seven cancer sites-the colon, rectum, liver, lung, breast, cervix, and prostate-registered between 2012 and 2014 in the NCI hospital-based cancer registry. Missing data were identified for coding completeness calculation among important variables. The agreement rate and κ coefficient were computed to represent data reliability.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">For reabstracting, we retrieved 957 medical records from a total of 5,462. These were selected using the probability proportional to size method, stratified by topology, sex, and registered year. The overall coding completeness of the registered and reabstracted data was 89.9% and 93.6%, respectively. In addition, the overall agreement rate among variables ranged from 84.7% to 99.6%, and κ coefficient ranged from 0.619 to 0.995. The misclassification among unilateral organs caused lower coding completeness and agreement rate of laterality coding. The completeness of current residency could be improved using the reabstracting method. The lowest agreement rate was found among various categories of diagnosis basis. Sex misclassification for male breast cancer was identified.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The coding completeness and data reliability of the NCI hospital-based cancer registry met the standard in most critical variables. However, some challenges remain to improve the data quality. The reabstracting method could identify the critical points affecting the quality of cancer registry data.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Sirirungreung</LastName>                    <ForeName>Anupong</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Anupong Sirirungreung, Phramongkutklao College of Medicine; Rangsiya Buasom and Suleeporn Sangrajrang, National Cancer Institute; and Chuleeporn Jiraphongsa, Field Epidemiology Training Program, Bangkok, Thailand.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Buasom</LastName>                    <ForeName>Rangsiya</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Anupong Sirirungreung, Phramongkutklao College of Medicine; Rangsiya Buasom and Suleeporn Sangrajrang, National Cancer Institute; and Chuleeporn Jiraphongsa, Field Epidemiology Training Program, Bangkok, Thailand.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jiraphongsa</LastName>                    <ForeName>Chuleeporn</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Anupong Sirirungreung, Phramongkutklao College of Medicine; Rangsiya Buasom and Suleeporn Sangrajrang, National Cancer Institute; and Chuleeporn Jiraphongsa, Field Epidemiology Training Program, Bangkok, Thailand.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sangrajrang</LastName>                    <ForeName>Suleeporn</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Anupong Sirirungreung, Phramongkutklao College of Medicine; Rangsiya Buasom and Suleeporn Sangrajrang, National Cancer Institute; and Chuleeporn Jiraphongsa, Field Epidemiology Training Program, Bangkok, Thailand.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Glob Oncol</MedlineTA>            <NlmUniqueID>101674751</NlmUniqueID>            <ISSNLinking>2378-9506</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Rev Bras Epidemiol. 2016 Oct-Dec;19(4):753-765</RefSource>                <PMID Version="1">28146165</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol. 2014 Oct;38(5):638-44</RefSource>                <PMID Version="1">25037979</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2011 Jun 28;105(1):170-6</RefSource>                <PMID Version="1">21559016</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Registry Manag. 2014 Summer;41(2):65-71; quiz 96-7</RefSource>                <PMID Version="1">25153011</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2011;12(1):173-8</RefSource>                <PMID Version="1">21517253</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2007 Apr 15;109(8):1607-16</RefSource>                <PMID Version="1">17343277</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2009 Mar;45(5):756-64</RefSource>                <PMID Version="1">19128954</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Med Res Methodol. 2016 Aug 05;16:93</RefSource>                <PMID Version="1">27495131</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol. 2015 Jun;39(3):456-64</RefSource>                <PMID Version="1">25863982</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 1993 Apr;67(4):819-21</RefSource>                <PMID Version="1">8471441</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Fam Med. 2005 May;37(5):360-3</RefSource>                <PMID Version="1">15883903</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2009 May;45(7):1218-31</RefSource>                <PMID Version="1">19091545</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Registry Manag. 2015 Fall;42(3):86-90</RefSource>                <PMID Version="1">27028092</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochem Med (Zagreb). 2012;22(3):276-82</RefSource>                <PMID Version="1">23092060</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Public Health. 1991 Jan;105(1):69-78</RefSource>                <PMID Version="1">2008506</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>ESMO Open. 2017 May 2;2(2):e000172</RefSource>                <PMID Version="1">28761745</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2009 Mar;45(5):747-55</RefSource>                <PMID Version="1">19117750</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2013 Feb 1;132(3):658-65</RefSource>                <PMID Version="1">22618962</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tutor Quant Methods Psychol. 2012;8(1):23-34</RefSource>                <PMID Version="1">22833776</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2011;12(12):3283-8</RefSource>                <PMID Version="1">22471467</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biomed Inform. 2008 Feb;41(1):24-32</RefSource>                <PMID Version="1">17452020</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2005 Feb 14;92(3):576-9</RefSource>                <PMID Version="1">15655546</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2010;11(3):735-8</RefSource>                <PMID Version="1">21039045</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30241269</ArticleId>            <ArticleId IdType="doi">10.1200/JGO.17.00147</ArticleId>            <ArticleId IdType="pmc">PMC6223438</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>